NCT06519110 2024-07-25
CVL009-C2001
Convalife (Shanghai) Co., Ltd.
Phase 2 Not yet recruiting
Clinical Trials
3 trialsNCT06374888 2024-04-19
Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases
Convalife (Shanghai) Co., Ltd.
Phase 2 Not yet recruiting
NCT05491057 2022-08-08
Treatment Patterns of Neratinib in HER2+ EBC in China
Pierre Fabre Medicament
Not yet recruiting